The MK-7622 is the first-of-its-kind oral positive allosteric modulator of M1 muscarinic receptors, developed by Merck for the treatment of Alzheimer’s disease, with a structure comprising a benzoquinazolinone bearing additional complex substituents at positions 3 and 6.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.